Clinical Trial Detail

NCT ID NCT02922777
Title Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

lung non-small cell carcinoma

Therapies

Bemcentinib + Docetaxel

Age Groups: adult senior

No variant requirements are available.